domatinostat,avelumab
merck,pfizer
pleasure to present the results of the emerge phase iib clinical trial using domatinostat and avelumab in metastatic mmrp oesophagogastric and colorectal adenocarcinomas in a poster discussion today #wcgic2022 
Medical oncology clinical research fellow at the Royal Marsden hospital in London